1. AASLD 2011BLINDED INDEPENDENT CENTRAL RESPONSE ASSESSMENT USING RECIST, MODIFIED RECIST, AND CHOI CRITERIA IN PATIENTS TREATED WITH SORAFENIB FOR ADVANCEDHEPATOCELLULAR…
Slide 1Hepatocellular Carcinoma: Progress at last Alan P. Venook, M.D. University of California, San Francisco Slide 2 Sorafenib in HCC Sorafenib in HCV patients: subset…